Presentations will showcase the company’s latest advances enabled by its CRISPR by Design TM approach to engineer safer and more effective in vivo genetic medicines for cardiometabolic disease ALAMEDA ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Programmable epigenome editing tightens control of timing CRISPR activation is only one piece of the timing puzzle, because cell fate is governed not just by which genes are present but by how ...

CRISPR-based therapy is a transformative approach to medicine that allows for targeted changes to the genome by directly addressing the source of disease, or to the epigenome through silencing of ...

Dr. Fyodor Urnov is a Professor of Genetics, Genomics, and Development at UC Berkeley and Scientific Director at the Innovative Genomics Institute, and a Co-Founder of Tune Therapeutics. His work ...